Abstract B135: Activity of Tegavivint in Hepatocellular Carcinoma with Aberrant Wnt/β-catenin Signaling and Evaluation of Biomarker Response
Ciara Curran(Foster Care Associates Scotland), Thomas G. Bird(MRC Centre for Regenerative Medicine), Aundrietta D. Duncan(Io Therapeutics (United States)), Toshiyasu Suzuki(Cancer Research UK), Stephen Horrigan(Translational Genomics Research Institute)
Cited by 0
Related Papers
TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence
|Science Translational Medicine|2018|259
TRIM24 Is a p53-Induced E3-Ubiquitin Ligase That Undergoes ATM-Mediated Phosphorylation and Autodegradation during DNA Damage
|Molecular and Cellular Biology|2014|106
Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation
|JHEP Reports|2021|69
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer
|Nature Communications|2021|43
β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer
|Cancer Immunology Research|2023|27